Navigation Links
Equine Obesity is Associated with Significant Health Issues, Including Insulin Resistance and Laminitis
Date:6/24/2009

Vet-A-Mix announces the release of an optimal nutritional supplement to support overall health and laminitis prevention for at-risk horses.

Shenandoah, IA (PRWEB) June 24, 2009 -- Equine obesity is on the rise in the United States. A large percentage of these horses are insulin resistant, and as such are at a higher risk for laminitis: a debilitating condition responsible for thousands of deaths each year. According to the USDA National Health Monitoring System, laminitis is the second most common reason for horses and ponies to present for veterinary care, yet 50% of these episodes can be prevented with effective nutritional management.

Vet-A-Mix, a Division of LLOYD, Inc. has recently introduced a simple and highly palatable solution for optimal dietary management of at-risk horses. The formula was developed in accordance to the Equine Cushing's and Insulin Resistance Group recommendations, and provides a complete, readily absorbable balance of vitamins, minerals, antioxidants and fatty acids ideal for the grass hay fed horse. Eleanor Kellon, VMD, a recognized expert in the field of horse nutrition, was instrumental in the final preparation. "We have found that careful attention to mineral balance and antioxidant nutrients in addition to controlled simple carbohydrates is both the safest and surest way to improve insulin resistance, control inflammation and regrow healthy hoof tissues." As the principal at Equine Nutritional Solutions (Ephrata, PA) and co-owner of the Equine Cushing's and Insulin Resistance Group Dr. Kellon consistently promotes properly balanced nutritional support, along with reduction in non-structural carbohydrates and increased exercise for these horses. "We are pleased to introduce Target IRTM to veterinarians and owners struggling to optimize the health of insulin resistant equids" states W. Eugene Lloyd, DVM, PhD, DABVT and CEO of LLOYD, Inc. "This clinically-validated formulation is poised to play a key role in helping to prevent laminitis and improving the quality and longevity of these horses."

For more information on equine insulin resistance, laminitis and related conditions, visit the Target IR webpage at: http://www.lloydinc.com/vet_equine_targetIR.html.

ABOUT LLOYD

LLOYD, Inc. (Shenandoah, IA), manufactures, tests and markets unique pharmaceutical and nutraceutical products for veterinary and human medicine. Working in partnership with more than forty distributors, LLOYD products can be found in virtually every veterinary clinic and school of veterinary medicine in the United States.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2564574.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Worlds First Portable, Battery-Operated, Equine-Dedicated CT Solution Installed at Penn Vets New Bolton Center
2. ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention
3. Fish Oil Fueling Equine Olympians
4. Equine Partners in Counseling (EPIC) Training Is Changing the Face of Mental Health
5. AVMA Opposes Use of Double-Deck Trailers for Transporting Horses and Other Equines
6. Fort Dodge Animal Health and the American Association of Equine Practitioners Launch Educational Web Site
7. Turning Pointe Therapeutic Riding Recognized for Excellence in Providing Equine-Assisted Therapies to People with Disabilities
8. ASPCA Provides Funding for Hay, Equine Expenses Following Outbreak of California Wildfires
9. Bioniche Responds to Australian Equine Influenza Outbreak
10. Obesity While Young Boosts Pancreatic Cancer Risk
11. 21st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using ... Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          ... boosting quality. , It’s known as the “CY2016 Annual FDA Medical Device Quality ...
(Date:7/20/2017)... ... 2017 , ... The Business Architecture Guild® is pleases to ... )v 6.0 is now available for member download. This release is dedicated to ... Non-members may download the Part 1 Introduction for free at http://www.businessarchitectureguild.org. ...
(Date:7/20/2017)... ... July 19, 2017 , ... A local summer ... increased funds raised to support fine arts programs in Chester County’s Elementary Schools. ... Freed-Hardeman University’s Loyd Auditorium. , More than 850 people attended the two ...
(Date:7/20/2017)... ... July 19, 2017 , ... ... million Health Resources and Services Administration (HRSA) grant to train predoctoral dental students ... care needs in rural and underserved areas. , The Predoctoral Pediatric Training Project ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: